R Bart Takkenberg

9PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersCancer diagnosisDisease surveillanceHaematological tumoursNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 01, 2026
Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial.

|Dec 28, 2025
Correct diagnosis of patients with fibrolamellar carcinoma: A Dutch nationwide study.

Alicia Furumaya, Abisha Gumede, Víola B Weeda

|Apr 30, 2025
Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Diederick J van Doorn, Kirsi M A van Eekhout, Koos de Wit

|Feb 08, 2024
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel

|Feb 10, 2023
Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality.

Koos de Wit, Thijs Kuipers, Koen Van der Ploeg

|Dec 04, 2022
Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.

Koos de Wit, Ulrich Beuers, Anna Mukha

Pageof 2

Frequent Collaborators

4 joint publications

Otto M van Delden

3 joint publications

Koos de Wit

3 joint publications

Ulrich Beuers

3 joint publications

Heinz-Josef Klümpen